What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
His primary areas of investigation include Internal medicine, Alzheimer's disease, Immunology, Disease and Genetics.
The various areas that Elio Scarpini examines in his Internal medicine study include Gastroenterology, Endocrinology, Oncology and Pathology.
His Alzheimer's disease research incorporates themes from Amyloid beta, Central nervous system disease, Neuroscience, Degenerative disease and Dementia.
His research in Immunology tackles topics such as Cerebrospinal fluid which are related to areas like Neurodegeneration.
His work focuses on many connections between Disease and other disciplines, such as Pharmacology, that overlap with his field of interest in Bioinformatics.
His studies in Genetics integrate themes in fields like Apolipoprotein E and Case-control study.
His most cited work include:
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease (1387 citations)
- Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease (1242 citations)
- Treatment of Alzheimer's disease; current status and new perspectives (560 citations)
What are the main themes of his work throughout his whole career to date?
Elio Scarpini focuses on Internal medicine, Disease, Pathology, Frontotemporal dementia and Genetics.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology and Oncology.
Elio Scarpini interconnects Gene, Immunology and Bioinformatics in the investigation of issues within Disease.
His Frontotemporal dementia study combines topics in areas such as Neuroscience and Atrophy.
His Allele study combines topics from a wide range of disciplines, such as Odds ratio, Apolipoprotein E and Genotype.
Elio Scarpini combines topics linked to Degenerative disease with his work on Alzheimer's disease.
He most often published in these fields:
- Internal medicine (29.39%)
- Disease (27.42%)
- Pathology (23.97%)
What were the highlights of his more recent work (between 2016-2021)?
- Frontotemporal dementia (19.87%)
- Disease (27.42%)
- Internal medicine (29.39%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Frontotemporal dementia, Disease, Internal medicine, Dementia and Pathology.
His Frontotemporal dementia research integrates issues from Neuroimaging, Neuroscience, Atrophy and Age of onset.
His Disease study focuses on Frontotemporal lobar degeneration in particular.
His Internal medicine study incorporates themes from Endocrinology, Oncology and Genotype.
He interconnects Episodic memory, Cognition, Cognitive impairment, Neuropsychology and Alzheimer's disease in the investigation of issues within Dementia.
His Pathology research incorporates themes from Positron emission tomography, Multiple sclerosis and Magnetic resonance imaging.
Between 2016 and 2021, his most popular works were:
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (429 citations)
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease (385 citations)
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease (385 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Disease
His main research concerns Frontotemporal dementia, Internal medicine, Multiple sclerosis, Dementia and Disease.
His Frontotemporal dementia research includes elements of Gene mutation, Neurology and Atrophy.
His Internal medicine research incorporates elements of Gastroenterology, Endocrinology and Oncology.
His Multiple sclerosis research is multidisciplinary, incorporating perspectives in White matter, Virology and Cerebrospinal fluid, Pathology.
His Dementia study integrates concerns from other disciplines, such as Psychiatry, Clinical trial, Neuropsychological assessment and Pathogenesis.
His Disease research is multidisciplinary, relying on both Gene and Central nervous system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
